Compare Pfizer Inc (PFE) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Procter & Gamble Co — how do they compare? Pfizer Inc trades at $28.28 (market cap $158.56B), while Procter & Gamble Co trades at $151.23 (market cap $349.77B). The key difference: Procter & Gamble Co is far larger — about 2.2× Pfizer Inc's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Procter & Gamble Co for 131 Days on average.
| PFE | PG | |
|---|---|---|
Market Cap | $158.56B | $349.77B |
Volume | 44,138,282 | 10,055,825 |
Sector | Health | Consumer Staples |
52-Week High | $29.02 | $167.18 |
52-Week Low | $23.67 | $138.10 |
Typical Hold Time | 158 Days | 131 Days |
Enterprise Value | $210.06B | $375.61B |
Dividend Yield | 6.18% | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Procter & Gamble (PG) trades at $151.23, up 2.31% with strong technical momentum above key support levels. The company demonstrates robust fundamentals with $84.28B revenue, 18.44% net margin, and consistent earnings beats. Recent partnership with the WNBA and supply chain enhancements support growth. Technical indicators show bullish moving averages while RSI remains neutral.
PG offers stable dividend income with 69-year growth history and trades near consensus target of $160.13. Premium valuation metrics present near-term risk if growth moderates. Strong cash flow generation and institutional support provide downside protection amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
